|
Lowering Dietary Fat May Help Prevent Prostate Cancer
Title: Lowering Dietary Fat May Help Prevent Prostate Cancer
Category: Health News
Created: 5/16/2008 2:00:00 AM
Last Editorial Review: 5/16/2008
Genes Play Part in Prostate Cancer Among Races
Title: Genes Play Part in Prostate Cancer Among Races
Category: Health News
Created: 5/16/2008 2:00:00 AM
Last Editorial Review: 5/16/2008
Pregnancy and Drugs (Prescription and OTC)
Title: Pregnancy and Drugs (Prescription and OTC)
Category: Diseases and Conditions
Created: 5/11/1999 12:22:00 PM
Last Editorial Review: 5/15/2008
Excess Drinking Boosts Cardiovascular Disease Risk
Title: Excess Drinking Boosts Cardiovascular Disease Risk
Category: Health News
Created: 5/15/2008 2:00:00 AM
Last Editorial Review: 5/15/2008
Urinalysis
Title: Urinalysis
Category: Procedures and Tests
Created: 11/27/1998 4:59:00 PM
Last Editorial Review: 5/14/2008
Penis Cancer
Title: Penis Cancer
Category: Diseases and Conditions
Created: 5/5/1999 7:28:00 AM
Last Editorial Review: 5/14/2008
Viagra to Treat Muscular Dystrophy?
Title: Viagra to Treat Muscular Dystrophy?
Category: Health News
Created: 5/13/2008
Last Editorial Review: 5/13/2008
Sex: 6 Sex Mistakes Men Make
Title: Sex: 6 Sex Mistakes Men Make
Category: Health Facts
Created: 5/13/2008
Last Editorial Review: 5/13/2008
Cushing's Syndrome
Title: Cushing's Syndrome
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 5/12/2008
Young Adults Using Alcohol, Drugs for Better Sex
Title: Young Adults Using Alcohol, Drugs for Better Sex
Category: Health News
Created: 5/10/2008 2:00:00 AM
Last Editorial Review: 5/12/2008
Newer Prostate Cancer Treatment Similar to Traditional Surgery
Title: Newer Prostate Cancer Treatment Similar to Traditional Surgery
Category: Health News
Created: 5/11/2008 2:00:00 AM
Last Editorial Review: 5/12/2008
Acrylamide in Diet: Cancer Risk?
Title: Acrylamide in Diet: Cancer Risk?
Category: Health News
Created: 5/12/2008
Last Editorial Review: 5/12/2008
MedicineNet Mens Health General
MedicineNet Mens Health General
Maxi-K Gene Transfer May Prove To Be Safe And Effective Erectile Dysfunction Treatment
Maxi-K gene therapy may be a safe and effective future option for men whose erectile dysfunction (ED) is not treatable with oral therapy. Two studies presented at the 103rd Annual Scientific Meeting of the American Urological Association (AUA) may give hope to these individuals. Researchers will present their findings to reporters in a special press conference on May 20, 2008 at 10 a.m.
Definition Of Premature Ejaculation By International Society For Sexual Medicine (ISSM)
Despite the fact that it has long been a major concern for men, an evidence-based definition for premature ejaculation has not existed until now. In October 2007, the International Society for Sexual Medicine (ISSM) gathered the world's leading sexual health experts to develop an evidence-based definition of premature ejaculation. Experts will present the definition to reporters in a special press conference on May 19th at Monday, May 19, 2008 at 10:00 a.m.
Erectile Dysfunction After External Beam Radiotherapy For Prostate Cancer
UroToday.com - Currently, the most common curative treatment options for men with localized prostate cancer are radical prostatectomy, external beam radiotherapy and interstitial permanent brachytherapy and radical prostatectomy. Treatment decisions should particularly consider the specific risk and toxicity profile of a treatment method.
New Penile Pump Could Improve Patient Satisfaction, Confidence
Erectile dysfunction (ED) has a dramatic impact on quality of life. Treatments for ED continue to improve, and penile prostheses have one of the highest patient satisfaction rates. In the April 2008 issue of Urologic Nursing, Susanne A. Quallich, Dana A. Ohl and Rodney L. Dunn survey urologic health care practitioners to find the penile prosthesis pump that is easiest to use and teach to patients.
Teaching Patients To Use Their Penile Prosthesis Requires Compassion
While penile prosthesis devices are the most invasive and least chosen treatments for erectile dysfunction (ED), the devices garner the highest patient satisfaction rates. In the April 2008 issue of Urologic Nursing, Annette Liechty and Susanne A. Quallich review a teaching process that nurses can use to show a patient to successfully operate the device.
Fewer Complications From Minimally Invasive Pancreas Surgery
When surgeons need to remove part of the pancreas, performing the operation with minimally invasive techniques offers patients a shorter hospital stay and fewer complications, researchers have concluded.A study of more than 660 operations to remove pancreatic tumors and cysts over five years found that after laparoscopic surgery, patients stayed a third less time in the hospital without experiencing more complications such as leaks.
Correlation Between Erectile Dysfunction And LUTS The AUA Lecture
UroToday.com - Dr. Kevin McVary (Chicago) presented the AUA lecture. The incidence of ED increases to over 60% by age 60. He showed data that ED increases with increasing severity of LUTS, independent of age. Across all age groups, increasing LUTS correlated with worse ED even after adjusting for other factors such as diabetes mellitus. This suggests a common pathophysiology or causal relationship between ED and LUTS.
Federal Authorities Seize More Than 100,000 Dollars Of Unapproved Drugs Marketed As "Natural Supplements"
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized more than 14,000 dosage units of Shangai Regular, Shangai Ultra, Super Shangai, Naturalë Super Plus, and Lady Shangai. Although labeled as natural supplements, the seized products were all marketed to treat erectile dysfunction (ED), impotency, and/or to provide sexual enhancement, which caused them to be drugs under the Federal Food, Drug, and Cosmetic Act.
VIVUS Enters Into 30 Million Dollars Funding Collaboration For The Phase 3 Studies Of Avanafil For Erectile Dysfunction
VIVUS, Inc. (NASDAQ: VVUS) announced that it has entered into a $30 million funding collaboration with Deerfield Management ("Deerfield"). Under the terms of the agreements, Deerfield will provide funds for the phase 3 program for avanafil, a fast-acting, highly selective, phosphodiesterase type 5 inhibitor (PDE5i) for the treatment of erectile dysfunction (ED).
Levitra® Therapy Suitable For Men With High Cholesterol
At the 23rd Annual European Association of Urology (EAU) Congress, results were presented which added evidence that Levitra® (vardenafil HCI) works very well in men with dyslipidemia.(1) The double-blind, placebo-controlled trial in about 400 men showed that Levitra® significantly improved the ability of men with erectile dysfunction (ED) and high cholesterol, to achieve and maintain an erection for successful sexual intercourse.(2) The trial, led by Dr.
Erection Hardness Scale Proves Effective In Assessing Erection Quality
The Erection Hardness Scale (EHS), an easy-to-use, four-point scale for erectile dysfunction (ED), provides a reliable measure of erection hardness and an indicator of other health and wellbeing outcomes, according to new data reported at the European Association of Urology. EHS rates the hardness of erection on a scale of one to four, with four being the maximal score.
High Levels Of The Molecule Adenosine Linked To Priapism
Priapism (prolonged penile erection in the absence of sexual interest) is common in male individuals with sickle cell disease (SCD), a blood disorder characterized by abnormally shaped red blood cells. Priapism is considered a medical emergency because it is associated with decreased blood flow to the erectile tissue, which can result in erectile tissue damage and, subsequently, erectile dysfunction and impotence.
Daily Vardenafil For 6 Months Has No Detrimental Effects On Semen Characteristics Or Reproductive Hormones In Men With Normal Baseline Levels
UroToday.com - This a randomized, double-blind, placebo controlled, parallel group, multicenter study involving 200 men with or without erectile dysfunction. Men (25-64 years of age) did not have ejaculatory dysfunction. Subjects were randomized to daily treatment with vardenafil, sildenafil or placebo for 6 months. Baseline sperm concentrations were compared to specimens acquired after 6 months of placebo or treatment.
Two Men Fined For Selling Erectile Dysfunction Drugs, UK
The Medicines and Healthcare products Regulatory Agency successfully prosecuted two men on 7 February 2008 at Bradford Magistrates Court for selling unlicensed medicines. David Tetley, (61) retired, and Stephen Evans, (49) unemployed, of 554 Leeds Road, Idle, Bradford, BD10 8JH, they pleaded guilty to the illegal sale and supply of Kamagra, Kamagra Oral Jelly and Loveagra.Tetley and Evans were advertising the drugs in 'Shout' a gay publication.
Cook Medical Launches Online Destination To Educate Physicians And Patients On A Leading Form Of Erectile Dysfunction
Cook Medical , announced the launch of www.MensHealthPD.
Slough Man Sentenced To Community Service For Peddling Counterfeit Medicines, UK
Mohammed Azim Dad (30) of 116 Chippenham Lane, Slough, SL1 5BA was sentenced to 250 hours community service on three counts under the Trade Marks Act 1994 relating to counterfeit erectile dysfunction medication, namely Viagra, Cialis and Levitra. Mr Dad appeared at Reading Crown Court following an investigation by the Medicines and Healthcare products Regulatory Agency (MHRA).
FDA Approves Cialis(R) (tadalafil) For Once Daily Use For The Treatment Of Erectile Dysfunction
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Cialis(R) (tadalafil)(1) for once daily use (2.5 mg and 5 mg), an oral medication taken once per day to treat erectile dysfunction (ED). When Cialis for once daily use is taken daily, men can attempt sexual activity at anytime between doses.
New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) In Men With Dyslipidemia, Including High Cholesterol
Results of the first prospective trial specifically designed to evaluate erectile function in erectile dysfunction (ED) patients with dyslipidemia show that LEVITRA(R) (vardenafil HCl), used in treating ED, significantly improves the ability of men with ED and dyslipidemia to achieve and maintain an erection for successful sexual intercourse. These data were presented at the Sexual Medicine Society of North America (SMSNA) Fall Meeting held in Chicago, IL.
Over-The-Counter Solution To Erectile Dysfunction
For couples worldwide, erectile dysfunction (ED) is one of the leading contributors to a man's inability to perform. As millions of men in America each year look for a solution, many seek alternative treatments to prescription medications and surgery that may have dangerous side effects.
New Patient Research Shows Importance Of Early Success In Treating Erectile Dysfunction
A UK study, made available at the 10th Congress of the European Society of Sexual Medicine in Lisbon, has warned healthcare professionals who treat erectile dysfunction (ED) of the importance of their first patient consultation.
Innovative Research Into Erectile Dysfunction In Diabetics Rewarded At ESSM Congress
The fourth annual ESSM Award of Excellence has been awarded to Professors Dr Carla Costa and Dr Pedro Vendeira for their ground-breaking research into erectile dysfunction in diabetics, during the 10th annual ESSM Congress taking place in Lisbon, Portugal. The study, entitled Bone-marrow Derived-cell Treatment for Diabetes-associated Erectile Dysfunction, provides new preliminary answers to erectile dysfunction that occurs earlier on in diabetics.
NexMed Confirms FDA Acceptance Of NDA For Erectle Dysfunction Product
NexMed, Inc. (Nasdaq: NEXM), a developer of innovative transdermal products based on its proprietary NexACT® drug delivery technology, announced that the New Drug Application (NDA) filed by the Company for its erectile dysfunction (ED) product, a topically applied alprostadil cream, was accepted for review by the U.S. Food and Drug Administration (FDA).
Sciele Pharma And Plethora Solutions Holdings PLC Announce Initiation Of Pivotal Phase III Trials For PSD502 For Premature Ejaculation
Sciele Pharma, Inc. ("Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, and Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, jointly announced that they have initiated patient enrollment for the Phase III clinical trials in the U.S. for PSD502 for the treatment of premature ejaculation. In May 2007, Sciele signed an exclusive licensing agreement for PSD502 with Plethora Solutions.
Have A Smoke Free Holiday
Smoking cigarettes causes cancer and increases the risk of cardiovascular and other diseases, but there's even more bad news for men who smoke. They have an increased risk of experiencing erectile dysfunction, and the more cigarettes smoked, the greater the risk, according to a study by Tulane University researchers published in the American Journal of Epidemiology.
FDA Reports Hearing Loss Linked To Viagra And Other PDE5 Inhibitors
The US Food and Drug Administration (FDA) has received reports of sudden reduction or loss of hearing following the use of PDE5 inhibitors, a class of drugs that includes the erectile dysfunction (ED) medications Viagra, Levitra, and Cialis and also Revatio, used to treat pulmonary arterial hypertension (PAH).
Erectile Dysfunction / Premature Ejaculation News From Medical News Today
Latest Erectile Dysfunction / Premature Ejaculation News From Medical News Today.
Cuba Increasing HIV Prevention Efforts Targeted At MSM, Health Official Says
Health officials in Cuba this year will focus HIV prevention messages at men who have sex with men, Rosaida Ochoa, director of the National Center for the Prevention of Sexually Transmitted Diseases and HIV, said recently, EFE News Service reports. Ochoa, who was speaking ahead of the International Day Against Homophobia on May 17, said that about 80% of people living with HIV in Cuba are men.
Brook Encourages Sexual Health Services To Be More Welcoming To Boys And Young Men, UK
Brook has launched research to encourage sexual health services to be more welcoming to boys and young men, Through the eyes of young men - a new vision for sexual health services, which looks at the reasons why young men do not make full and effective use of sexual health services. Boys and young men make up just 20% of Brook's clients with lack of information and mistaken expectations stopping them from using services.
Penile Traction Therapy For Treatment Of Peyronie's Disease: A Single-Center Pilot Study
UroToday.com - The pilot study and ongoing clinical experience indicates the vital importance of patient compliance if an improved outcome is to be gained from use of the Fastsize penile traction device. During the time of the study, other patients at the study site were being treated with intralesional Verapamil injections, a more aggressive treatment modality, with the expectation that superior outcomes would be achieved.
Nation's Largest Medical Specialty Organization Issues New Guideline For Screening For Osteoporosis In Men
Osteoporosis is often viewed as a women's health issue, but one in 16 men over 65 suffers from the disease, and few men are currently tested or diagnosed. Because of the aging population, a dramatic increase in osteoporosis among men is expected in the near future. New recommendations from ACP call for physicians to screen for osteoporosis in older men, especially those over the age of 65.
Screening For Osteoporosis In Men, Comprehensive Clinical Practice Guideline - American College Of Physicians [Includes Video]
A new clinical practice guideline on screening for osteoporosis in males has been released by the ACP (American College of Physicians). Studies have revealed that osteoporotic fractures cause a significant number of diseases, raised health costs, and deaths among men.
Gay Men's Sexual Health Helpline And Face To Face Service Launched In London By THT Direct, UK
The Terrence Higgins Trust helpline, THT Direct, is launching two new services today. The first is the London Gay Men's Sexual Health Helpline and the second is a face to face service for people who would prefer to speak to an advisor in person, rather than over the phone. The London Gay Men's Sexual Health Helpline will be available on 0845 231 0600 from 10am - 10pm Monday to Friday and 12pm - 6pm Saturday and Sunday.
Egyptian Actors Address HIV/AIDS, Recent Imprisonment Of Men Living With Disease
Egyptian actors Amr Waked and Khaled Abul Naga are speaking out against HIV/AIDS-related stigma in the country after several people who are allegedly living with the disease have been jailed in recent months, AFP/Yahoo! News reports.
Listening To The Urinary Stream Microphone Replaces Catheter For Diagnosis Of Voiding Symptoms
Benign prostate enlargement affects most of the elder men and often compresses the urethra resulting in voiding symptoms. Dutch researcher Tim Idzenga has found a way to measure the resistance of the urethra using sound: via a microphone placed behind the scrotum. The sound spectrum of the recorded sound depends on how much the urethra has been compressed.
Chicago Tribune Profiles Home For HIV-Positive Men
The Chicago Tribune recently profiled the Jo-Ray House, a home for HIV-positive men in Chicago. Jo-Ray was founded in 2003 by Ida Byther-Smith, who was diagnosed as HIV-positive in 1991. Byther-Smith has qualified for grants from the
John Prescott Battled Bulimia For Ten Years
Ex-Deputy Prime Minister, UK, John Prescott, 69, battled in silence with eating disorder bulimia for ten years. In a BBC interview Prescott says the shame of being a high-profile figure with the illness kept him in silence. In a Sunday Times article he says he used to consume huge quantities of food - which might include the entire menu of a Chinese restaurant, plus a whole tin of condensed milk and trifle, and then he would vomit.
AHRQ And Ad Council Encourage Men To Take Preventive Steps In Their Health Care, USA
The U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) joined with The Advertising Council today to launch a national public service campaign designed to raise awareness among middle-aged men about the importance of preventive medical testing.
The Uncommon Tale Of A Man's Struggle With Anorexia
Every month or so, the popular media are saturated with stories of thelatest Hollywood starlet's eating disorder. However, it is rare to hearof males who are suffering with anorexia, bulimia, or other disorders.In his forthcoming autobiography, former deputy prime minister JohnPrescott has admitted to the public that he began his struggle withbulimia in the 1980s.
Depression: Less-Educated Men More Prone To Stigma
Personal stigma associated with depression is higher among men and the less well educated, according to research published in the open access journal BMC Psychiatry. The findings by the Australian team highlight the importance of developing programs to tackle the stigma associated with depression.
Stopping Maternity Services From 'shutting Out' The Father
Today a 12-point action plan was published aimed at stopping maternity services throughout the United Kingdom from disadvantaging children from birth by shutting out their dads. According to The Fatherhood Institute, the report The Dad Deficit: The Missing Piece of the Maternity Jigsaw presents "a mass of evidence" which demonstrates that a father's active and positive involvement, starting before the birth of a child offers profound extra benefits.
Kenyan Government Adopts Male Circumcision As A Standard HIV Prevention Strategy
The Kenyan government has issued a new policy to adopt male circumcision as a standard HIV prevention strategy, Kenya's Nation reports. The Policy on Male Circumcision in Kenya 2008 calls for the procedure to be provided to all willing males. The decision to adopt circumcision as an HIV intervention follows
Young Macho Men With Serious Injuries Often Abuse Alcohol
Men with serious injuries, such as traumatic brain injury or spinal cord injury, must deal with a range of emotions. If these men have strong traditional masculine ideas and abuse alcohol, it becomes even more difficult to help them heal and come to terms with their emotions and situations.
Free Seminar: Bioidentical Hormone Therapy
BodyLogic MD's Dr. Hank Wagner will share his expertise on hormone imbalance and discuss how bioidentical hormone therapy can help both men and women suffering from the symptoms of andropause (the male menopause) and menopause. "This seminar will offer men and women information about the specialized approach of bioidentical hormone therapy to treat the symptoms related to hormone imbalance, menopause and andropause and how it works to prevent disease and promote wellness," said Dr.
Testosterone Replacement Therapy (TRT) Beneficial In Men 60 And Older
The risk of osteoporosis (bone fracture) in women is highly recognized by the public. Less appreciated is the fact that the disorder also occurs in men. Some two million males have been diagnosed with osteoporosis and another three million are at risk. Gender-based hormones and age are thought to be major factors behind bone fractures in both sexes. Women with low levels of estrogen and men with low levels of the testosterone are known to be at risk.
Grand Prix Launch For New TENA For Men - Puts Men In Control! UK
TENA, the UK's leading bladder weakness brand has launched a brand new product designed exclusively for the male market - TENA for Men. With 3.6 million men in the UK with bladder control difficulties, it is a far more common problem than most people realise. There are two TENA products specifically engineered for men with mild to moderate bladder weakness, both retailing at £4.49 per box.
Florida Advocacy Group Launches HIV/AIDS Education, Testing Campaign Aimed At MSM
COMPASS, a Palm Beach County, Fla.-based gay and lesbian advocacy group, last week launched an HIV/AIDS education and testing campaign aimed at men who have sex with men, the Palm Beach Post reports. The campaign encourages MSM to sign cards pledging to promote HIV testing to 10 other people.
Fathers Still 'Shut Out' From Birth Of Their Children, Report Claims, UK
Leading fatherhood think-tank the Fatherhood Institute will launch a 12 point action plan on April 14, over claims that maternity services across the UK are disadvantaging children from birth by 'shutting out' their fathers.
Los Angeles Times Examines Male Circumcision In The U.S.
The Los Angeles Times on Monday examined male circumcision in the U.S. and factors that some parents consider when deciding whether to have their infant boys circumcised, including a reduced risk of HIV. According to the Agency for Healthcare Research and Quality, 56% of infant boys in the U.S.
Why High School Boys Dodge 'Phys Ed'
As obesity and inactivity among youth becomes a growing concern for North American families, new research based at The University of Western Ontario is asking why some high school boys are reluctant to participate in Grade 9 health and physical education classes.
Higher Risk Of Suicide Found In Young Black Men Compared To Their White Counterparts
A study examining suicide rates and pre-suicide clinical symptoms in people from different ethnic groups, has found that rates of suicide vary between ethnic groups with young black men aged 13 to 24 at highest risk.The research, published in the medical journal Psychiatric Services, suggests that symptoms traditionally associated with suicide are less common among some ethnic groups, and cannot be relied upon for predicting suicide.
Men's health News From Medical News Today
Latest Men's health News From Medical News Today.
Complications Of Open Radical Retropubic Prostatectomy In Potential Candidates For Active Monitoring
UroToday.com - Active monitoring with delayed intervention for prostate cancer (CaP) is an increasingly utilized strategy. However, due to a stage shift migration, men are now diagnosed with much earlier and perhaps more indolent CaP. In the online version of Urology, Dr. Stacy Loeb and associates of Dr. William Catalona evaluate the surgical complications of their patients who underwent radical prostatectomy (RP), but were candidates for active monitoring (AM).
Higher Cholesterol Increases Risk Of Boichemical Failure After Radical Prostatectomy
Poor cholesterol management may not only affect a man's risk for prostate cancer, but also his risk of biomedical recurrence after prostatectomy, according to new data from Duke University.
Study Shows That Prostate Cancer Increases The Risk Of Bone Fracture
As unlikely as it sounds, scientists at the Garvan Institute for Medical Research have shown that there is a link between prostate cancer and a higher risk of bone fracture. Analysis of data from Garvan's Dubbo Osteoporosis Epidemiology Study suggests that men with prostate cancer face a 50% higher risk of fracture, which increases to nearly doubled risk if they are receiving treatment. The results have just been published online in the prestigious international journal Bone.
External-Beam Radiation Therapy For Localized Prostate Cancer Linked To Bladder, Lung And Colorectal Cancer
Patients undergoing external-beam radiation therapy (EBRT) for localized prostate cancer may be at an increased risk for secondary malignancy, according to a study from researchers in Canada, Italy and the United States presented during the Annual Scientific Meeting of the American Urological Association (AUA) in Orlando. Researchers will present data to reporters during a special press conference on May 19, 2008 at 1:30 p.m.
New Study Strengthens Association Of Prostate Cancer With Exposure To Agent Orange In Vietnam Veterans
As men age, their risk of developing prostate cancer increases. Aging Vietnam veterans are giving researchers new opportunities to solidify the connection between in-country exposure to Agent Orange and subsequent prostate cancer development.
Vitamin D Protects Cells From Stress That Can Lead To Cancer
By inducing a specific gene to increase expression of a key enzyme, vitamin D protects healthy prostate cells from the damage and injuries that can lead to cancer, University of Rochester Medical Center researchers report."Many epidemiological studies have suggested the beneficial properties of vitamin D," said Yi-Fen Lee, associate professor of urology at the Medical Center who led the research.
FDA Approves HIFU Clinical Trial For Recurrent Prostate Cancer
USHIFU, the clinical trial management provider for Focus Surgery, Inc. (Indianapolis, IN), is pleased to announce conditional written approval pending minor changes to the protocol from the FDA to begin a pivotal trial for the treatment of recurrent prostate cancer with the Sonablate(R) 500 in men who have failed external beam radiation therapy. Dr.
Saturated Fat Intake Predicts Biochemical Failure After Prostatectomy
UroToday.com - In the online version of the International Journal of Cancer, Dr. Sara Strom and associates evaluate the association between saturated fat intake and biochemical failure among men who underwent radical prostatectomy (RP).
Residual Prostate Cancer After Radiotherapy: Study Of Radical Cystoprostatectomy Specimens
UroToday.com - In the online version of Urology, Dr. Kaplan and associates at Fox Chase Cancer Center report on residual prostate cancer (CaP) after radiotherapy (RT) in men undergoing radical cystoprostatectomy for bladder indications. Between 1990 and 2007, 21 patients had a cystoprostatectomy for cancer (19), radiation cystitis (1) and rectal cancer (1). A total of 17 had external beam RT and 4 had brachytherapy.
Erectile Dysfunction After External Beam Radiotherapy For Prostate Cancer
UroToday.com - Currently, the most common curative treatment options for men with localized prostate cancer are radical prostatectomy, external beam radiotherapy and interstitial permanent brachytherapy and radical prostatectomy. Treatment decisions should particularly consider the specific risk and toxicity profile of a treatment method.
Cleveland BioLabs Completes Recruitment For Phase II Hormone-Refractory Prostate Cancer Trial
Cleveland BioLabs, Inc. (NASDAQ: CBLI), announced that it has fully enrolled its Phase II clinical trial of Curaxin CBLC102 in advanced, hormone-refractory (androgen independent) prostate cancer. This open label trial is evaluating the safety and efficacy of Curaxin CBLC102 for use in treating patients with hormone-refractory metastatic prostate cancer.
Prostate Cancer Breakthrough Receives FDA Clearance
A new imaging device, ei•Nav/Artemis™, now officially cleared by the U.S. Food and Drug Administration (FDA), offers urologists breakthrough technology that will significantly help in the fight against prostate cancer. Artemis, designed by Eigen, a Northern California-based company known for developing innovative, affordable medical imaging solutions, will be introduced at the American Urological Association's (AUA) annual meeting May 17 - 22 in Orlando, FL.
Youths In Towns With Smoke-Free Restaurant Laws Appear Less Likely To Become Smokers
Young people who live in towns where regulations ban smoking in restaurants may be less likely to become established smokers, according to a report in the May issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals. Many studies have examined the risk factors that lead young people to try their first cigarette, according to background information in the article.
Flower Power May Bring Ray Of Sunshine To Cancer Sufferers
A mini-protein found in sunflower seeds could be the key to stopping tumours spreading in prostate cancer patients, according to QUT researchers.
Natural History Of Pathologically Organ-Confined (pT2), Gleason Score 6 Or Less, Prostate Cancer After Radical Prostatectomy
UroToday.com - According to a report from Dr. Hernandez and colleagues at Johns Hopkins University that appears in the online version of Urology, men with prostate cancer (CaP) who undergo radical prostatectomy (RP) and have organ confined disease with Gleason score 6 or less are very unlikely to experience disease recurrence.A retrospective review identified 2,526 men between 1983 and 2005 who underwent RP, either open (2,422) or laparoscopic (104).
Long-Term Prediction Of Prostate Cancer
UroToday.com - In the February 20, 2008 issue of the Journal of Clinical Oncology, Dr. Ulmert and associates suggest that PSA velocity (PSAV) does not add to PSA in predicting the long-term risk of prostate cancer (CaP). The study was performed using the Malmö Preventive Medicine database, and included 4,907 men who had a blood sample drawn between 1974 and 1986 to investigate risk factors for cardiovascular and metabolic diseases.
Initial Extended Transrectal Prostate Biopsy-Are More Prostate Cancers Detected With 18 Cores Than With 12 Cores?
UroToday.com - Increasing the number of prostate biopsy cores from 10 to 18 is reported to increase the prostate cancer (CaP) detection rate from 30% to 41%. In the April 2008 issue of the Journal of Urology, Dr. Scattoni and associates retrospectively analyzed the detection rates of CaP, high-grade PIN (HGPIN), and atypical glands suggestive of carcinoma (AGSC) in patients undergoing either 18 or 12 core prostate biopsies.
Testosterone Levels In Benign Prostatic Hypertrophy And Prostate Cancer
UroToday.com - The introduction of PSA for the diagnosis of prostate carcinoma has undoubtedly increased the detection rate of localized tumours. As PSA has low specificity, particularly in screening programmes, surrogates are being sought e.g. PSA density, velocity or free/total ratio. Despite this, a reliable, easy to use, marker of prostate cancer still remains to be found.
Is Prostate Specific Antigen Velocity Selective For Clinically Significant Prostate Cancer In Screening?
UroToday.com - With the knowledge that screening for prostate cancer will lead to over detection and subsequent over treatment, the call for tests discriminating between non aggressive and aggressive prostate cancer is growing. If pre-biopsy data could make this distinction, a lot of unnecessary biopsies would be spared. The amount of prostate cancer specific antigen (PSA) increase in a year, PSA velocity (PSAV), has been suggested as a factor predictive for aggressive disease.
When To Wait And When To Treat? New Program Will Search For Biomarkers In Men With Prostate Cancer To Help Find An Answer
Researchers at Fred Hutchinson Cancer Research Center have a lead role in a new public/private partnership to create the first systematic surveillance program of men with prostate cancer to look for biological clues to help determine when to wait and when to treat the disease. The project was announced by the Canary Foundation and the National Cancer Institute. Peter Nelson, M.D.
Malignancy Potential Of HG-PIN Lesions In The Prostate Predicted By Biomarker
Men whose prostate cancer screenings show high grade prostatic intraepithelial neoplasia (HG-PIN) may find themselves in limbo, "stuck" between diagnoses - they are told prostate cancer has not yet developed, but it might, and they are advised to undergo repeated needle biopsies as a precaution.Investigators from Spain have found a means of distinguishing between HG-PIN lesions destined to become cancerous and those which will remain benign.
A Mini-Protein Found In Sunflower Seeds Could Be The Key To Stopping Tumors Spreading In Prostate Cancer Patients, According To QUT Researchers
Flower power may bring ray of sunshine to cancer sufferersThe grants came from Queensland Cancer Research, the Prostate Cancer Foundation, and the National Health and Medical Research Council."We are interested in this miniprotein as a potential treatment of prostate cancer, in particular for those patients who relapse," said Dr Harris.
Nymox Announces New Positive Results At 54 Months In Long Term Study Of NX-1207 For Benign Prostatic Hyperplasia
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced new positive results from a long term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). The study evaluated symptomatic progress of U.S. patients involved in the Company's two Phase 1-2 studies initiated in 2003.
Health Discovery Corporation Announces Successful Clinical Trial Results For New Molecular Diagnostic Test For Prostate Cancer
Health Discovery Corporation ("HDC") (OTCBB: HDVY) announced the successful clinical trial results for HDC's new molecular diagnostic test for prostate cancer licensed exclusively to Clarient (Nasdaq:CLRT), in which HDC will receive a 30 percent royalty based on reimbursements received by Clarient from third parties.
New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin Like Growth Factor Receptor
Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results, especially if a major tumor suppressor gene -- p53 -- is already compromised, according to new research by investigators at Fred Hutchinson Cancer Research Center.
Prostate / Prostate Cancer News From Medical News Today
Latest Prostate / Prostate Cancer News From Medical News Today.
| 